Immunotherapy is a cornerstone in the treatment of melanoma, and is intended to modulate
the host immunity against the tumor. Immunotherapy can be used in an adjuvant setting …

Simple Summary Immunotherapy has demonstrated the ability to reduce the risk of
recurrence for melanoma following surgical resection and improve survival in patients with …

Worldwide incidence of malignant melanoma has been constantly increasing during the last
years. Surgical excision is effective when primary tumours are thin. At later disease stages …

Immunotherapy has dramatically improved the prognosis for patients with melanoma and
has become the cornerstone of treatment for those with advanced disease. The role of …

Immunotherapy is an important modality in the therapy of patients with malignant melanoma.
As our knowledge about this disease continues to expand, so does the immunotherapeutic …

Metastatic melanoma is notorious for its immune evasion and resistance to conventional
chemotherapy. The recent success of ipilimumab, a human monoclonal antibody against …

Immunotherapy for advanced melanoma has progressed dramatically in the last five years
with the approval of immune checkpoint inhibitors targeting cytotoxic T lymphocyte …

The incidence of melanoma is increasing worldwide and despite early detection and
intervention, the number of patients dying from metastatic disease continues to rise. The …

The incidence of melanoma is increasing worldwide and despite early detection and
intervention, the number of patients dying from metastatic disease continues to rise. The …

The immunotherapy is currently changing the landscape of oncology. Nowadays the
standard of care in metastatic or unresectable melanoma patients include …